BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3500754)

  • 21. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
    Lembersky BC; Ratain MJ; Westbrook C; Golomb HM
    Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remission in hairy cell leukaemia achieved with pentostatin.
    Spiers AS; Parekh SJ
    Lancet; 1984 May; 1(8385):1080-1. PubMed ID: 6144012
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
    Ho AD; Ganeshaguru K; Knauf WU; Dietz G; Trede I; Hunstein W; Hoffbrand AV
    Blood; 1988 Dec; 72(6):1884-90. PubMed ID: 3264192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
    Spiers AS
    Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the choice of treatment for hairy cell leukemia?
    Golomb HM; Ratain MJ; Moormeier J
    J Clin Oncol; 1989 Feb; 7(2):156-8. PubMed ID: 2783730
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia.
    Daenen S; Rojer RA; Smit JW; Halie MR; Nieweg HO
    Br J Haematol; 1984 Dec; 58(4):723-7. PubMed ID: 6097297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.
    Poplack DG; Sallan SE; Rivera G; Holcenberg J; Murphy SB; Blatt J; Lipton JM; Venner P; Glaubiger DL; Ungerleider R; Johns D
    Cancer Res; 1981 Sep; 41(9 Pt 1):3343-6. PubMed ID: 6973390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trials in hairy cell leukemia. Current status and future directions.
    Cheson BD; Martin A
    Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
    Yu AL; Mendelsohn J; Matsumoto SS
    Adv Exp Med Biol; 1986; 195 Pt A():491-6. PubMed ID: 3487920
    [No Abstract]   [Full Text] [Related]  

  • 32. Exploiting biochemical differences in leukemia.
    Coleman MS; Grever MR
    Adv Exp Med Biol; 1984; 165 Pt B():315-20. PubMed ID: 6609538
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia.
    Prentice HG; Russell NH; Lee N; Ganeshaguru K; Blacklock H; Piga A; Smyth JF; Hoffbrand AV
    Lancet; 1981 Dec; 2(8258):1250-4. PubMed ID: 6118669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin).
    Riddell S; Johnston JB; Rayner HL; Israels LG
    Cancer Treat Rep; 1986 Apr; 70(4):546-8. PubMed ID: 3084084
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms.
    Spiers AS; Ruckdeschel JC; Horton J
    Scand J Haematol; 1984 Feb; 32(2):130-4. PubMed ID: 6608139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
    Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
    Spiers AS; Parekh SJ
    Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deoxycoformycin: a new chemotherapeutic agent of interest to dermatologists.
    Camisa C; Grever MR; Bouroncle B
    J Am Acad Dermatol; 1985 Jun; 12(6):1108-9. PubMed ID: 3874216
    [No Abstract]   [Full Text] [Related]  

  • 40. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
    Spiers AS; Parekh SJ; Bishop MB
    J Clin Oncol; 1984 Dec; 2(12):1336-42. PubMed ID: 6334721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.